MEDFORD, MASSACHUSETTS – January 4, 2021 – Travera, LLC has announced that it has moved from its 1,000 sq.ft. laboratory in Cambridge, Massachusetts to a 3,500 sq.ft. lab in Medford, Massachusetts. This new location remains near the Massachusetts Institute of Technology (MIT), the company’s key technology partner. This new, larger lab space will enable Travera to apply for CLIA certification and scale up its production of CLIA certified tests that embody its novel cancer biomarker.
Travera was founded in 2017 to commercialize a breakthrough measurement technology and biomarker developed in the Manalis Laboratory in the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT). The company’s initial test is based on this technology; a new measurement tool called the Suspended Microchannel Resonator (SMR) that makes exquisitely precise measurements of the effects of cancer drugs on cancer cells.